Gao, Xiaopan http://orcid.org/0000-0002-1435-6636
Zhu, Kaixiang
Qin, Bo
Olieric, Vincent http://orcid.org/0000-0002-0533-7222
Wang, Meitian http://orcid.org/0000-0002-5340-3036
Cui, Sheng http://orcid.org/0000-0001-6329-3582
Article History
Received: 20 January 2021
Accepted: 16 April 2021
First Online: 14 May 2021
Competing interests
: The patent protecting the design and application of the C-peptide (including its derivatives) originated from SARS-CoV-2 orf9b sequence is pending by the authors of this paper and the Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, China. The authors declare no other competing interests.